Viewpoints of dentists on the use of bisphosphonates in rheumatology patients

Daron, Coline; Soubrier, Martin; Mathieu, Sylvain

doi:10.1111/idj.12363

Cited by 2 publications

(8 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Regarding the knowledge of MRONJ among DDS, it was found that younger dentists and recent graduates mastered the subject better (Daron et al, 2018;Patil et al, 2020;Escobedo et al, 2018;Ozkan et al, 2021;Arnaud et al, 2022;Bruckmoser et al, 2021). Moreover, DDS register the medications used by their patients, however, most do not ask the reason why they are being used (Daron et al, 2018;Han, 2021). When it comes to the indications and adverse effects of BP, few professionals knew how to correctly answer the therapeutic indications of antiresorptive and antiangiogenic medications, their trade names, and side effects associated with the oral cavity (Patil et al, 2020;Arnaud et al, 2022;Miranda-Silva et al, 2020).…”

Section: Dds Knowledge On Mronjmentioning

confidence: 99%

Section: Dds Knowledge On Mronjmentioning

confidence: 99%

“…Regarding confidence in their knowledge about BPs and MRONJ, most DDS did not feel comfortable with performing surgical procedures on patients using these medications because they thought that their knowledge of the management of these cases might be insufficient (Daron et al, 2018;Patil et al, 2020;Dahlgren & Larsson, 2020).…”

Section: Dds Knowledge On Mronjmentioning

confidence: 99%

“…Bisphosphonates (BPs) are antiresorptive drugs widely used to treat some types of cancer, such as breast, prostate, and lung, when there is bone metastasis. BPs are also widely prescribed by rheumatologists for fracture prevention in patients with osteopenia and osteoporosis, and in the treatment of Paget's disease and osteogenesis imperfecta (Ruggiero et al, 2022;Daron et al, 2018).…”

Section: Introductionmentioning

confidence: 99%

“…Although BPs are able to treat cancer, reduce fractures and improve patients' quality of life, these drugs have side effects, among which is Medication-related Osteonecrosis of the Jaw (MRONJ) (Ruggiero et al, 2022;Daron et al, 2018).…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Medication-related osteonecrosis of the jaw and the role of the doctor of dental surgery: a literature review

Cabral

Santiago

Silva

et al. 2023

RSD

View full text Add to dashboard Cite

Introduction: Medication-related Osteonecrosis of the Jaw (MRONJ) is a condition that may affect patients undergoing oral surgery procedures that use antiresorptive drugs. It is essential that the Doctor of Dental Surgery (DDS) is familiar with the pathology and how to diagnose, prevent and approach it. Objectives: To perform a literature review on MRONJ and to guide the DDS on how to manage the affected patients. Methodology: a systematized search was conducted on the PubMed virtual database using the terms: "diphosphonates", "dentist's practice pattern", "dentists", "dentist's role" and "Bisphosphonate-Associated Osteonecrosis of the Jaw". 29 articles in English, published in the last 5 years, were included. Results and discussion: MRONJ is characterized by exposed and necrotic bone that persists for more than 8 weeks and happens in patients taking antiresorptive agents. It is multifactorial and its severity depends on the dosage, route of administration, and treatment duration. Its management must be multidisciplinary to improve the patient's quality of life. The DDS must focus on prevention. Every patient should have their oral health evaluated before starting antiresorptive therapy and be informed of its risks and benefits. Most DDSs do not feel confident to adequately manage these cases, even though information on MRONJ is more widespread among younger DDSs and recent graduates. Conclusion: MRONJ is a harmful condition for the patient and it is the DDS's responsibility to know how to treat and prevent it, by having adequate knowledge of this pathology and making decisions based on the latest scientific evidence.

show abstract

Section: Dds Knowledge On Mronjmentioning

confidence: 99%

Section: Dds Knowledge On Mronjmentioning

confidence: 99%

Section: Dds Knowledge On Mronjmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Medication-related osteonecrosis of the jaw and the role of the doctor of dental surgery: a literature review

Cabral

Santiago

Silva

et al. 2023

RSD

View full text Add to dashboard Cite

show abstract

Medication-related osteonecrosis: Literature review

Idrovo Campoverde María Coralía,

Bacuilima Ñauta Erika Susana,

Pesántez Alvarado Juan Martín

et al. 2023

World J. Adv. Res. Rev.

View full text Add to dashboard Cite

Objective: The aim of this study is to determine the most likely medication to develop osteonecrosis of the jaw, the route of administration, dose and treatment time that carry the greatest risk, and to establish appropriate prevention strategies in order to provide new knowledge for the management of patients who are at risk or that are developing medication-related osteonecrosis of the jaw. Materials and methods: Literature review of the last 5 years in the databases PubMed, ScienceDirect and Springer Link, using the following terms: osteonecrosis in dentistry, osteonecrosis of the jaws and drug related osteonecrosis of the jaws. Results: A total of 20,662 articles were obtained from the three digital databases; after applying exclusion and inclusion criteria, 51 articles were selected for the literature review. Conclusion: MRONJ is a rare but potentially serious condition associated with prolonged use of antiresorptive and antiangiogenic agents. However, because of the heterogeneity of evidence, the administration route of greatest risk has not been accurately determined.

show abstract

Viewpoints of dentists on the use of bisphosphonates in rheumatology patients

Abstract: Dentists feel ill at ease providing dental surgery to patients receiving BPs. Closer collaboration and better information-sharing between rheumatologists and dentists is necessary to facilitate the administration of BPs in rheumatology.

Cited by 2 publications

References 29 publications

Medication-related osteonecrosis of the jaw and the role of the doctor of dental surgery: a literature review

Medication-related osteonecrosis of the jaw and the role of the doctor of dental surgery: a literature review

Medication-related osteonecrosis: Literature review

Contact Info

Product

Resources

About